Fig. 2From: Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective studyOverall Survival analysis of rPDAC patients who received chemotherapy compared to those who did not. The median OS for those who received chemotherapy (broken lines) was 10 months compared to 3 months without chemotherapy (solid line). Log—rank p < 0.0001Back to article page